Table 2 Microsatellite changes in colorectal cancer patients.

From: More subtle microsatellite instability better predicts fluorouracil insensitivity in colorectal cancer patients

Patient code

Microsatellite

Treatment

D2S123

D5S107

D10S197

D13S175

D17S250

MSI

F01

A

  

A

 

A+

mFOLFOX6

F02

     

-

mFOLFOX6

F03

     

-

mFOLFOX6

F04

A

    

-

mFOLFOX6

F05

    

A

-

mFOLFOX6

F06

 

A

  

A

A+

mFOLFOX6

F07

     

-

mFOLFOX6

F08

A

 

A

 

A

A+

mFOLFOX6

F09

     

-

mFOLFOX6

F10

A

   

A

A+

mFOLFOX6

F11

     

-

mFOLFOX6

F12

 

A

   

-

mFOLFOX6

F13

     

-

mFOLFOX6

F14

 

A

  

A

A+

mFOLFOX6

F15

A

    

-

mFOLFOX6

F16

     

-

mFOLFOX6

F17

     

-

mFOLFOX6

F18

  

A

 

A

A+

mFOLFOX6

F19

(ND)

A

A

B

A

A+

mFOLFOX6

F20

  

A

  

-

CAPOX

F21

    

A

-

CAPOX

F22

    

A

-

CAPOX

F23

     

-

CAPOX

F24

     

-

CAPOX

F25

     

-

CAPOX

F26

A

 

A

 

A

A+

CAPOX

F27

  

A

 

A

A+

CAPOX

F28

A

 

A

 

A

A+

CAPOX

F29

     

-

CAPOX

F30

A

   

A

A+

CAPOX

  1. A Type A MSI, B Type B MSI, CAPOX capecitabine and oxaliplatin, mFOLFOX6 fluorouracil, oxaliplatin and leucovorin, ND not determined.